Inventor
Sarah KUTSCHER
Inventor
DE
Overview
Patents· 11 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C07KPeptides20%
C12NMicroorganisms or enzymes20%
G01NInvestigating or analysing materials by determining their chemical or physical properties20%
PatentTitleYear
12,121,572Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers202412,097,248Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers202412,076,380Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers202412,070,491Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers202411,786,583Peptides and combination of peptides for use in immunotherapy against Hepatocellular carcinoma (HCC) and other cancers202311,779,638Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells202311,679,147Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells202311,672,848Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells202311,576,956Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers202311,559,573Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells202311,406,693Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to IMMATICS BIOTECHNOLOGIES GMBH (11)· patent assignee history
2022–2024Based in DE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IMMATICS BIOTECHNOLOGIES GMBH | 11 | 2022–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| DE | 11 | 2022–2024 |